Upgrade to SI Premium - Free Trial

Impax Laboratories (IPXL) PT Lowered to $17 at Cowen Following Announced Deal with Amneal

October 17, 2017 11:42 AM
Cowen lowered its price target on Impax Laboratories (NASDAQ: IPXL) to $17.00 (from $20.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles